Literature DB >> 12372750

Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils.

Michael J Workman1, Harry J Cloft, Frank C Tong, Jacques E Dion, Mary E Jensen, William F Marx, David F Kallmes.   

Abstract

BACKGROUND AND
PURPOSE: Thromboembolic events are a common source of complications during Guglielmi detachable coil (GDC) treatment of intracranial aneurysms. Thrombus formation at the coil-parent artery interface is not commonly reported but is an important potential source of emboli. We describe nine cases in which thrombus propagated from GDCs into the parent artery during coil therapy of cerebral aneurysms and subsequent treatment of the thrombus.
METHODS: A retrospective review of a procedural database was performed to identify cases in which thrombus occurred during GDC treatment of cerebral aneurysms during a 30-month period. All images were reviewed at the time of the procedure. Nine cases of thrombus forming at the coil-parent artery interface and five cases of distal emboli were identified among 210 cases. All patients underwent anticoagulation with heparin during GDC treatment procedures.
RESULTS: Thrombus was identified at the coil-parent artery interface during GDC treatment in nine (4.3%) of 210 cases. In each case, the thrombus was recognized before distal embolic complication occurred and was successfully treated with heparin alone (five patients) or with heparin plus a glycoprotein IIb-IIIa inhibitor (four patients).
CONCLUSION: Potential clinical complications can be avoided by early recognition of thrombus at the coil-parent artery interface and by administering appropriate medical therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372750      PMCID: PMC7976790     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  29 in total

1.  Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization.

Authors:  T E Lempert; A M Malek; V V Halbach; C C Phatouros; C F Dowd; R T Higashida
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

Review 2.  Thrombosis and anticoagulation.

Authors:  J Hirsh; J I Weitz
Journal:  Semin Hematol       Date:  1999-10       Impact factor: 3.851

3.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

4.  Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor.

Authors:  R C Wallace; A J Furlan; D J Moliterno; G H Stevens; T J Masaryk; J Perl
Journal:  AJNR Am J Neuroradiol       Date:  1997-08       Impact factor: 3.825

5.  Intracranial berry aneurysms: angiographic and clinical results after endovascular treatment.

Authors:  C Cognard; A Weill; L Castaings; A Rey; J Moret
Journal:  Radiology       Date:  1998-02       Impact factor: 11.105

6.  Endovascular treatment of basilar tip aneurysms using Guglielmi detachable coils: anatomic and clinical outcomes in 73 patients from a single institution.

Authors:  S Tateshima; Y Murayama; Y P Gobin; G R Duckwiler; G Guglielmi; F Viñuela
Journal:  Neurosurgery       Date:  2000-12       Impact factor: 4.654

Review 7.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Authors:  J Hirsh; T E Warkentin; R Raschke; C Granger; E M Ohman; J E Dalen
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

8.  Dissociation between the anti-aggregatory & anti-secretory effects of platelet integrin alpha IIb beta 3 (GPIIb/IIIa) antagonists, c7E3 and DMP728.

Authors:  P W Tsao; M S Forsythe; S A Mousa
Journal:  Thromb Res       Date:  1997-10-15       Impact factor: 3.944

9.  Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool.

Authors:  C J White; S R Ramee; T J Collins; A E Escobar; A Karsan; D Shaw; S P Jain; T A Bass; R R Heuser; P S Teirstein; R Bonan; P D Walter; R W Smalling
Journal:  Circulation       Date:  1996-01-15       Impact factor: 29.690

10.  Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects: comparison to angiography.

Authors:  B F Uretsky; B G Denys; P C Counihan; M Ragosta
Journal:  Cathet Cardiovasc Diagn       Date:  1994-12
View more
  33 in total

1.  Ventriculostomy-related cerebral hemorrhages after endovascular aneurysm treatment.

Authors:  Ian B Ross; Gurmeet S Dhillon
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

2.  Letter to the editor. Anticoagulant and antithrombotic agent use in intracranial aneurysm treatment call for a consensus.

Authors:  A Poulios; W Mukonoweshuro
Journal:  Interv Neuroradiol       Date:  2006-02-10       Impact factor: 1.610

3.  The mechanism of catheter kickback in the final stage of coil embolization for aneurysms: the straightening phenomenon.

Authors:  S Miyachi; T Izumi; N Matsubara; T Naito; K-I Haraguchi; T Wakabayashi
Journal:  Interv Neuroradiol       Date:  2010-12-17       Impact factor: 1.610

4.  Endovascular treatment of intracranial aneurysms with matrix coils: immediate posttreatment results, clinical outcome and follow-up.

Authors:  T Jonas Kimchi; R A Willinsky; J Spears; S K Lee; K ter Brugge
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

5.  Endovascular treatment of middle cerebral artery aneurysms: A single center experience with a focus on thromboembolic complications.

Authors:  Thomas W Link; Srikanth R Boddu; Hoda T Hammad; Jared Knopman; Ning Lin; Pierre Gobin; Athos Patsalides
Journal:  Interv Neuroradiol       Date:  2017-10-31       Impact factor: 1.610

6.  Abciximab for thrombolysis during intracranial aneurysm coiling.

Authors:  Jan Gralla; Adam T M Rennie; Rufus A Corkill; Shivendra T Lalloo; Andrew Molyneux; James V Byrne; Wilhem Kuker
Journal:  Neuroradiology       Date:  2008-09-20       Impact factor: 2.804

Review 7.  Is eptifibatide a safe and effective rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization? Single-center experience in 42 cases and review of the literature.

Authors:  Jacques Sedat; Yves Chau; Lydiane Mondot; Richard Chemla; Michel Lonjon; Bernard Padovani
Journal:  Neuroradiology       Date:  2013-11-27       Impact factor: 2.804

8.  Characterizing patterns of endothelialization following coil embolization: a whole-mount, dual immunostaining approach.

Authors:  Daying Dai; Yong-Hong Ding; Issa Rezek; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2015-02-02       Impact factor: 5.836

9.  Thrombus formation during intracranial aneurysm coil placement: treatment with intra-arterial abciximab.

Authors:  Joon K Song; Yasunari Niimi; Patricia M Fernandez; Jonathan L Brisman; Razvan Buciuc; Mark J Kupersmith; Alejandro Berenstein
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

10.  Multiple antiplatelet therapy contributes to the reversible high signal spots on diffusion-weighted imaging in elective coiling of unruptured cerebral aneurysm.

Authors:  Toshinori Matsushige; Yoshihiro Kiura; Shigeyuki Sakamoto; Takahito Okazaki; Katsuhiro Shinagawa; Nobuhiko Ichinose; Miyuki Takasu; Yuji Akiyama; Kazuhiko Sugiyama; Kaoru Kurisu
Journal:  Neuroradiology       Date:  2013-01-12       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.